We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia Seeks Stronger Warnings on CV Risks of Anti-Inflammatories
Australia Seeks Stronger Warnings on CV Risks of Anti-Inflammatories
Australia’s medicines authority is urging tougher warnings on the cardiovascular risks of over-the-counter nonsteroidal anti-inflammatory drugs, as well as new initiatives to inform patients about the risks associated with both OTC and prescription versions of the painkillers.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor